Rationale: Although substantial scientific evidence suggests that chronic exposure to ambient air pollution contributes to premature mortality, uncertainties exist in the size and consistency of this association. Uncertainty may arise from inaccurate exposure assessment. Objectives: To assess the associations of three types of air pollutants (fine particulate matter, ozone [O 3 ], and nitrogen dioxide [NO 2 ]) with the risk of mortality in a large cohort of California adults using individualized exposure assessments. Methods: For fine particulate matter and NO 2 , we used land use regression models to derive predicted individualized exposure at the home address. For O 3 , we estimated exposure with an inverse distance weighting interpolation. Standard and multilevel Cox survival models were used to assess the association between air pollution and mortality.
What This Study Adds to the Field
To address this potential problem, this study assigned members of the American Cancer Society Cancer Prevention Study II Cohort residing in California more precise exposure assignments at their home address using advanced exposure models. The study provides the first evidence that ozone is significantly associated with cardiovascular mortality, particularly from ischemic heart disease; shows a strong association between nitrogen dioxide (NO 2 ) and lung cancer; and demonstrates that that fine particulate matter with aerodynamic diameter of 2.5 mm or less (PM 2.5 ) and NO 2 associate independently with premature death from all causes and cardiovascular disease. The findings from this study confirm earlier evidence on PM 2.5 associations with mortality and expand the evidence base markedly on associations between ozone or NO 2 and premature death.
Using data from the American Cancer Society's (ACS) Cancer Prevention Study II (CPS-II), a nationwide cohort study of nearly 1.2 million adults who have been followed for mortality since 1982, several studies have been published examining associations of metropolitan-level air pollution and mortality (3, (9) (10) (11) . In those studies, exposure data were derived at the metropolitan scale, relying on between-city exposure contrasts using central monitor data.
In addition, two studies using CPS-II data evaluated withincity (i.e., Los Angeles and New York) exposure contrasts in fine particulate matter with aerodynamic diameter of 2.5 mm or less (PM 2.5 ) (2, 3) . Both studies assigned exposure to the ZIP code postal area of residence, but in the study from Los Angeles (2) , the PM 2.5 -mortality dose-response relationship was stronger than that for the full nationwide cohort, and in the study from New York City, the relationship was weaker (3) . Although the ZIP code areas were more specific than the metropolitan area, they may have introduced error in the exposure assignment that led to the inconsistent results. Another recent study based on individualized exposures found little association between PM 2.5 exposure and mortality in a cohort of male health professionals (12) ; however, in that study if home address records were missing, then workplace addresses were used for exposure assignment, possibly leading to measurement error. Conversely, an earlier study based on a large cohort of nurses reported strong and significant associations of PM 2.5 with mortality, using essentially the same exposure model but with complete home address information for exposure assignment (13) . Viewed together, these findings suggest that uncertainties in the characterization of the dose-response relationship may be due partly to the errors in exposure estimates arising from the lack of specificity of the coordinates used to link addresses to the exposure estimates. A need therefore exists to investigate how individualized estimates of exposure at the home address influence the observed dose-response function.
In the present analysis, individualized exposure estimates were developed and assigned to the home address for more than 73,000 California residents enrolled in CPS-II. These estimates were used to assess the association of three types of air pollutants (PM 2.5 , ozone [O 3 ], and nitrogen dioxide [NO 2 ]) with risk of mortality. We also sought to understand the joint effects of the pollutants in co-and multipollutant models. Although CPS-II is a nationwide cohort, we limited this analysis to California because the state has a wide range of pollution exposures and a good monitoring network.
METHODS
The ACS CPS-II cohort was enrolled in 1982 (details are presented in References 3 and 14) . For the purposes of this paper, vital status was ascertained through to 2000. Subjects with valid postal addresses had their residential locations geocoded. After limiting to residence in the State of California and making exclusions for missing data on key covariates, there were 73,711 subjects available for analysis.
We assigned exposure for PM 2.5 , NO 2 , and O 3 . Monthly average monitoring data for PM 2.5 were available at 112 sites between 1998 and 2002. NO 2 and O 3 data were available over the period 1988 to 2002 at 138 and 262 sites, respectively. PM 2.5 and NO 2 exposures were assessed using land use regression (LUR) models that were selected from more than 70 possible land use covariates (15) . The PM 2.5 model included an advanced remote sensing model coupled with atmospheric modeling (16) . LUR models were selected with the deletion/substitution/addition algorithm (17) . The deletion/substitution/addition algorithm, which aggressively tests nearly all polynomial covariate combinations, uses v-fold cross-validation to evaluate potential models. In this instance of v-fold cross-validation, data are first partitioned into 10 roughly equal parts (i.e., folds). The model is then trained on nine folds and cross-validated on the left out fold. This is repeated 10 times so every fold is used as a cross-validation data set. The model selection method avoids the potential problems of over-fitting on all the data or on a large training set and then using a cross-validation subset (details presented References 15 and 18). For O 3 , we extracted monthly averaged values from 1988 to 2002 and calculated the inverse distance weighting (IDW) models with the decay parameter set to the inverse of the square of the distance from all sites within a 50-km radius of operational monitors during any particular month. Estimates for all pollutants were then assigned to geocoded baseline residential addresses of the CPS-II subjects, and the monthly values were averaged for the entire time period available.
We used a comprehensive set of individual risk factor variables operationalized through 42 covariates similar to those used in previous studies of the CPS-II cohort (3, 18) . Individual-level variables controlled for lifestyle, dietary, demographic, occupational, and educational factors, and ecological variables extracted from the 1990 US Census in the ZIP code of residence were used to control for potential "contextual" neighborhood confounding (including unemployment, poverty, income inequality, and racial composition).
We assessed the association between air pollution and mortality using standard and multilevel Cox proportional hazards regression models. Control for place of residence was also applied in the five largest conurbations-defined by the four consolidated metropolitan statistical areas of California and the metropolitan statistical area of San Diegothat potentially have lower mortality rates than nonmetropolitan areas. This pattern is consistent with what has been termed the "nonmetropolitan mortality penalty," where nonmetropolitan areas tend to have higher death rates compared with metropolitan areas (19) . Because metropolitan areas generally have higher pollution, failure to control for residence in large urban areas has the potential to confound associations between mortality and air pollution. We evaluated the association between air pollution and several causes of death, including cardiovascular disease (CVD), ischemic heart disease (IHD), stroke, respiratory disease, and lung cancer. We also evaluated "all other" causes of death, excluding the preceding causes, to serve as a negative control. Finally, we evaluated mortality from all causes combined. Table 1 compares characteristics of the nationwide CPS-II cohort used in previous analyses to the subset selected for this analysis (a detailed description of exclusions and sample selection is provided in Reference 18). Minor differences in alcohol consumption and education are apparent, but overall the California cohort appears to have characteristics similar to the nationwide cohort. Subjects included in this analysis were widely distributed across California, giving comprehensive coverage for much of the State's population (54/58 California counties were represented). Table 2 shows the mean, variance, and percentiles of each pollutant as estimated by the different models used in this study. All models display considerable variation in the exposures assigned to the home address. Most pollutants show moderate to high positive correlations ( Table 3 ). The exception is between interpolated ozone and NO 2 estimates, which displays a weak negative correlation.
RESULTS
Estimates of adjusted relative risk (RR) and 95% confidence intervals (CIs) are reported in Table 4 . All RR estimates are given over the interquartile range of each pollutant. We assessed residual spatial autocorrelation in the health effect estimates with a multilevel Cox model (3) . Because the multilevel clustering and autocorrelation analysis had minimal impact on the risk estimates, only results for the standard Cox models are reported.
For PM 2.5 we observed significantly elevated RR for mortality from all causes (RR, 1.032; 95% CI, 1.002-1.068), CVD (RR, 1.064; 95% CI, 1.016-1.114), and IHD (RR, 1.111; 95% CI, 1.045-1.181). Deaths from stroke, respiratory causes, and lung cancer had positive RRs with less precision and CIs that included unity. No association is present with other causes. NO 2 is significantly and positively associated with all-cause (RR, 1.031; 95% CI, 1.008-1.056), CVD (RR, 1.048; 95% CI, 1.010-1.087), IHD (RR, 1.066; 95% CI, 1.015-1.119), stroke (RR, 1.078; 95% CI, 1.016-1.145), and lung cancer (RR, 1.111; 95% CI, 1.020-1.210) mortality. Respiratory deaths and those from all other causes were not associated with NO 2 .
Although there was no association between O 3 and all-cause mortality, there was a positive association with CVD mortality (RR, 1.045; 95% CI, 0.986-1.108) and a significantly elevated risk for IHD death (RR, 1.104; 95% CI, 1.021-1.194). O 3 had a positive association with stroke and respiratory deaths that lacked precision and a marginally significant negative association with deaths from lung cancer. There was no association with other causes.
We compared the risk estimates obtained from single-pollutant models with risk estimates from two-pollutant and multipollutant models ( Table 5 ). In models that included PM 2.5 and NO 2 , the PM 2.5 associations with mortality from all causes were reduced to about half the size of those in the single pollutant models, and the estimates became insignificant. When O 3 and PM 2.5 were included in the same all-cause mortality model, the effects from PM 2.5 remained significantly elevated and became slightly larger. A similar pattern was observed with CVD and IHD, where the effects of PM 2.5 were attenuated with NO 2 but remained unchanged in the presence of the O 3 estimates ( Figure 1 ).
The NO 2 associations with CVD and IHD were attenuated when PM 2.5 was included in the model, but they became slightly larger when O 3 was included. O 3 continued to show elevated risks for CVD and IHD in the two-pollutant models with either NO 2 or PM 2.5 included. For respiratory deaths, PM 2.5 continued to have elevated but insignificant risk estimates, whereas neither of the other pollutants was associated with respiratory mortality. For lung cancer, NO 2 consistently displayed significantly elevated risks in two-pollutant models. When combined with O 3 , PM 2.5 associations with lung cancer increased but remained insignificant.
In multipollutant models containing all three pollutants, NO 2 had the strongest associations with all-cause mortality and CVD and with lung cancer, whereas PM 2.5 tended to have stronger effects on deaths from IHD. Intercorrelations among the various pollutants, however, likely contribute to bias in individual pollutant risk estimates in such simultaneous pollutant models, so these results must be interpreted with caution. In multipollutant models, PM 2.5 continued to produce elevated risks for all-cause, CVD, IHD, and respiratory mortality, but none of these estimates were statistically significant. O 3 had elevated risks on CVD and remained a significant predictor of IHD deaths even with the other pollutants in the model.
There was little evidence of associations with the other causes of death in the two-pollutant or multipollutant models. Figure 1 presents results from cumulative risk index (CRI) models for CVD and IHD mortality that show the extent to which one pollutant confounds the others (details of the CRI methods are provided in the online supplement). Comparisons of CRI based on combinations of pollutants estimated jointly and independently can also provide a means of understanding the joint impacts of the atmospheric mixture on survival. For example, with CVD mortality, the combined hazard ratio (HR) of NO 2 and O 3 assuming independence is 1.048 3 1.045 ¼ 1.095. However, the combined HR based on the two-pollutant survival model is 1.121, suggesting a synergy of effect among the pollutants. A similar pattern of synergy is also observed for IHD mortality.
Such a comparative assessment is illustrated in Figure 1 for three pollutants (NO 2 , O 3 , and PM 2.5 ) and two causes of death (CVD and IHD). The HRs evaluated at their respective interquartile ranges for the three pollutants are presented singly, based on the three possible two-pollutant models, and based on the single threepollutant model. There is some modest increase in the CRI for models containing PM 2.5 and either NO 2 or O 3 compared with each of the single-pollutant models. The model with NO 2 and O 3 , however, is larger than either of the other two-pollutant models and has a similar CRI to the three-pollutant model, suggesting that a combination of NO 2 and O 3 is sufficient to characterize the toxicity of the pollutant mixture in this study, at least with respect to the three pollutants considered.
The CRI implies that there is little marginal contribution to CVD and IHD mortality from the addition of PM 2.5 in the presence of the mixture represented by NO 2 and O 3 . We also caution that in this interpretation the CIs clearly overlap each of the CRIs we have calculated. This limits our ability to infer the set of minimally sufficient pollutants required to fully capture the toxicity of the atmosphere in California.
DISCUSSION
We sought to estimate the effects of three criteria air pollutants on premature death in California. This study was motivated by earlier research from Los Angeles that showed PM 2.5 exerted a large significant effect on all-cause mortality and mortality from CVD. Other studies, including those based on data from the ACS CPS-II, showed heterogeneous health effect estimates that potentially resulted from a lack of precision in the exposure assessment. To address this problem, we developed detailed exposure assessment models that included auxiliary information and assigned resulting estimates of exposure to the baseline residential address of more than 73,000 subjects with valid data from the ACS CPS-II cohort.
Several important results deserve mention. First, findings of associations of PM 2.5 with all-cause and cardiovascular mortality are consistent with those reported from our previous analyses of the full, nationwide CPS-II cohort (3) . Table 6 shows that results for all-cause, CVD, and IHD mortality from the current study are similar, although they are slightly weaker than from the study of the nationwide cohort. The difference in exposure metrics had little impact on the risk estimates for PM 2.5 . We also fit models specifically for Los Angeles to compare with earlier results (2) . Although the sample size is different here due to limitations in the geocoding, the results show that the effects in Los Angeles continue to be higher than those in the national study or in the rest of the state. We also examined the dose-response function for nonlinearity because levels in Los Angeles are generally higher than in many other parts of the state, but we found no evidence of nonlinearity in the dose-response function based on visual inspection of spline plots and formal measures of model fit (Akaike information criteria and Bayesian information criteria results not shown). This suggests that the population of Los Angeles is more susceptible to air pollution, that the air pollution there is more toxic, or both.
The strongest associations with mortality appear to be for exposures that are markers for traffic-related air pollution. The largest predictors of NO 2 in the LUR model were measures of roadway length near the monitors, although we cannot rule out other contributions to the modeled concentrations, such as heating and industrial sources, particularly given the generally higher (20). This exposure measure demonstrated significant associations with all-cause, CVD, IHD, and lung cancer mortality. In multipollutant models, these associations remained elevated but became insignificant in some models, possibly due to multicollinearity among the pollutants. We also examined direct measures of proximity to roadways in earlier studies (18) and found these markers of traffic had positive coefficients, but the findings were null, suggesting that the improved exposure estimates with the LUR model may have reduced exposure measurement error. Our results are broadly consistent with several studies from Europe in which NO 2 exposure was positively associated with mortality (21, 22) . In an American study of male truck drivers, NO 2 was found to be independently associated with all-cause and cause-specific mortality even after controlling for occupational exposures (23) . In a comprehensive review by the Health Effects Institute, effects of traffic-related pollution on mortality were identified as suggestive but insufficient to establish a causal association (24) . When viewed in the context of the emerging literature, our results strengthen the evidence base on the effects of traffic-related air pollution on mortality.
Although acute exposure to O 3 has been related to mortality (25), here we observed a significant positive association between long-term O 3 exposure and CVD mortality, notably for IHD. The strength of association for O 3 was similar to that of PM 2.5 and NO 2 . The association of O 3 with IHD was mildly confounded by PM 2.5 ; however, the two exposures had moderately high correlation, and, given the extensive auxiliary information in the PM 2.5 model, the PM 2.5 estimates may have dominated by virtue of lower exposure measurement error (26) . Nevertheless, O 3 continued to exhibit a significant association with IHD, even with PM 2.5 in the model.
Positive RR estimates for O 3 became larger when NO 2 was included in the model (see Figure 1 ). We hypothesize that this results from the negative correlation between the two pollutants due to the atmospheric chemistry, such that in areas where O 3 is high, NO 2 tends to be low, and vice versa (27, 28) . If both pollutants represent harmful constituents of the complex mixture of ambient air pollutions, each would contaminate the comparison for calculating "clean" atmospheres when assessing the risk of the other pollutant. In such instances, the comparison groups with lower pollution levels may also have higher mortality, resulting in part from higher levels of the other pollutant that occupies the opposite spatial pattern. We found a negative, significant association between O 3 and lung cancer, which became insignificant when NO 2 was included in the model. These findings together suggest the importance of having both O 3 and NO 2 in models that attempt to predict health effects from either pollutant. We did observe a weak negative correlation between the two pollutants; however, subsequent analyses showed that in four of the five major urban regions of California, NO 2 had moderately high negative correlations with O 3 (details are provided in the online supplement), which supports the possibility of the positive confounding we have observed here and of the hypothesis that both pollutants need to be in the model for correct inference on either.
Unlike previous analyses (14), we did not see a significant association between respiratory disease and O 3 . In the present analysis, however, the number of respiratory deaths was much smaller than in the earlier national study. The point estimate here was elevated and of similar size to that reported in an earlier analysis of the nationwide cohort (3); consequently, the lack of significant association may have resulted from the lower event numbers. In contrast to earlier results, PM 2.5 did have a positive association with respiratory mortality, which tended to get stronger with the inclusion of copollutants, particularly O 3 . In the correlational analyses done by major urban regions (see APPENDIX), we observed significant negative correlations between O 3 and PM 2.5 suggesting again the potential for positive confounding. * Models for both risk estimates control for an identical set of individual risk factors (e.g., smoking) and contextual risk factors (e.g., unemployment in area of residence) and are stratified by age, race, and sex. Results for the California cohort are additionally adjusted for place of residence in five major urban conurbations. The follow-up period for all studies was from 1982 to 2000.
y California and Los Angeles use residential address with a land use regression estimate of exposure results using standard Cox model. z The national-level study uses metropolitan area of residence with the average of all fine particulate matter (PM 2.5 ) monitors within the metropolitan area as the exposure estimate; results were determined using two-level random effects assuming no spatial autocorrelation.
x Values are relative risk with 95% confidence interval in parentheses.
Several strengths and limitations merit mention. For NO 2 and PM 2.5 , we used advanced exposure assessment models informed by auxiliary information that had good predictive capacity. These models, however, were based on government monitoring data, and the placement of the government monitoring sites might be less representative of all exposure domains because they are chosen to represent background conditions. For the most part, near-road environments are not well represented in this network, limiting the ability to predict small-area variations near roadways. Our estimates of O 3 exposure likely do not capture the small area variation that can occur in open space areas and other areas away from roadways (27) . Nonetheless, by assigning exposures that vary among individuals within cities, this study extends the applicability of the risk estimates to support studies that have an interest in assessing the health impacts of air pollutants within cities, which is being increasingly done to justify the health benefits of urban planning and climate mitigation interventions (29, 30) .
Regarding limitations, there were no follow-up surveys conducted in the full CPS-II, and key lifestyle characteristics may have changed during the follow-up (e.g., smoking rates declined precipitously across California between 1982 and 2000) (31) . If the declines in smoking rates were spatially associated with the air pollution levels, these would have the potential to confound our air pollution risk estimates. We also lacked information on mobility during the follow-up and on key microenvironments such as in-transit exposures, which contribute substantially to interindividual variability in air pollution exposures (32) .
In conclusion, our results suggest that several components of the combustion-related air pollution mixture are significantly associated with increased all-cause and cause-specific mortality. Associations with CVD deaths in general and with IHD in particular stand out as most consistent in our analyses. The strong associations of NO 2 with all-cause, CVD, and lung cancer mortality are suggestive of traffic-related pollution as a cause of premature death. The potential for positive confounding between O 3 and NO 2 requires increased attention in future research. Given the indications that O 3 may relate significantly to CVD mortality, future research may lead to refined O 3 exposure assessment with lower measurement error. In sum, the associations observed here reduce key uncertainties regarding the relationship between air pollution and mortality and confirm that air pollution is a significant risk factor for mortality.
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Spatiotemporal Analysis of Air Pollution and Mortality in California Based on the American Cancer Society Cohort: Final Report
ABSTRACT Problem: Studies using the American Cancer Society (ACS) Cancer Prevention II (CPS II) cohort to assess the relation between particulate air pollution and mortality rank among the most influential and widely cited. The original study, a reanalysis that introduced new random effects methods and spatial analytic techniques, and recent studies with longer follow-up and improved exposure assignment, have all demonstrated statistically significant and substantively large air pollution effects on all-cause and cause-specific mortality. Due to this robust association and a lack of other large cohort studies on the long-term effects, the ACS studies have proven important to government regulatory interventions and health burden assessments.
At present there are no ACS CPS II statewide studies in California that investigate whether the risks are similar to or different from those reported in the above-mentioned analyses. Existing estimates come from either national-level ACS studies, in which the California subjects comprise less than 15% of the total national sample, or from select metropolitan or county areas of California, where questions remain about their generalizability to the rest of the state. A need therefore exists to investigate whether the results hold across California. In addition, none of the existing ACS studies have used high-resolution exposure assignment or investigated the temporal dimensions of the dose-response relationship. In this study we used advanced exposure modeling to reduce problems of measurement error, and we investigated time windows of exposure.
Previous Work: Our previous work includes the original ACS study of particulate air pollution and mortality, the reanalysis of the ACS study, as well as studies involving analytic extensions to both these studies using new spatial models, and a study providing the first assessment of particulate air pollution at the within-city or "intraurban" scale using Los Angeles as the test site. Our Los Angeles results suggest the chronic health effects associated with intraurban gradients in exposure to fine particulate matter (PM 2.5 ) are even larger than those previously reported for the metropolitan areas used in both the original study by Pope et al. [1] and the reanalysis by Krewski et al. [2] . For the within-city models, we observed effects nearly three times greater than those using models relying on between-community exposure contrasts. These findings were confirmed using more refined exposure models in a subsequent Health Effects Institute report [3] . In that report, we also found risks for the national study that were greater than those in earlier studies for deaths due to cardiovascular causes.
Objectives:
In this context, we pursued the following research objectives: (1) to derive detailed assessments of the health effects from particulate and gaseous air pollution on all-cause and cause-specific mortality in California based on the ACS CPS II cohort, (2) to investigate whether specific particle characteristics associate with larger health effects through examination of intraurban gradients in exposure to different particle constituents and sources, and (3) to determine whether critical exposure time windows exist in the relationship between air pollution and mortality in California.
Description:
We identified more than 76,000 California subjects in the ACS cohort to serve as the study population (20, 432 deaths with an 18 year follow-up ending in 2000). These subjects were widely distributed across California, giving comprehensive coverage for much of the 6 population of the state (i.e., 54 of 58 California counties have ACS subjects). For the first time in using the ACS CPS-II data, we have geocoded subjects to their home address to refine our exposure assignment.
As a basis for exposure assessment, we utilized interpolation estimates derived by Air Resources Board staff for the California Teachers Cohort Study led by Dr. Michael Lipsett, with Dr. Jerrett as co-investigator. We also implemented geostatisical kriging, advanced remote sensing coupled with atmospheric modeling, land use regression, and Bayesian models capable of assessing space-time patterns in exposure to improve exposure assignment.
We employed a comprehensive set of 20 individual risk factor variables similar to those used in previous ACS studies. These variables control for lifestyle, dietary, demographic, occupational, and educational influences that may confound the air pollution-mortality association. We used ecological variables in the neighborhoods of residence to control for "contextual" neighborhood confounding (e.g., unemployment). Although we used similar variables as in previous analyses to promote comparison to earlier results, we also tested other model specifications.
We assessed the association between air pollution and several causes of death, including cardiovascular (CVD), ischemic heart disease (IHD), respiratory, lung cancer, and other causes. We also evaluated all-cause mortality. There is some debate about the efficacy of evaluating associations between all-cause mortality and air pollution because several causes of deaths in this broad categorization likely have little association with air pollution. We have included the allcause metric for several reasons. First, the all-cause metric has been used in most of the other published studies to date, and therefore we used this outcome for comparability with previous results. Second, the all-cause measure avoids the potential cross-classification bias between respiratory and CVD deaths. Third, the all-cause metric can be useful in burden of mortality assessments, and it has been used extensively for this purpose. Finally, we use the all-cause metric to compare with the cause-specific effects that we hypothesized should be more strongly related to pollution exposures (i.e., CVD deaths). A related point is the use of the combined "all other" causes of death to serve as a negative "control". The overall results are more compelling if one observes associations only for those causes of deaths for which there exists biological plausibility or where previous results have provided an a priori hypothesis (CVD, IHD, lung cancer), and where the risks for all other effects are null.
We assessed the association between air pollution and death using standard and multilevel Cox proportional hazards models. Control was also applied for residence in the five largest urban conurbations, which potentially have different mortality rates than non-metropolitan areas. We also assessed spatial autocorrelation in the health effect estimates.
Key Results: Below we summarize the key results from our investigation.
1. Cardiovascular disease (CVD) deaths, especially those from ischemic heart disease (IHD), are consistently and robustly associated with measures of fine particulate and traffic-related air pollution. The effects on CVD and IHD in California are virtually identical to those of the national ACS study (see Abstract Table 1 ). Table 9 ; CVD estimate produced for this report for comparison with the California using the same model and sample as in the Krewski report (i.e., two level random effects, with no spatial autocorrelation -referred to as MSA and DIFF in Table 9 ). Note numbers slightly differ from the Krewski report due to rounding.
Models for both risk estimates control for individual risk factors (e.g., smoking), contextual risk factors (e.g., unemployment in area of residence) and are stratified by age, race and sex. Results for the California cohort are also additionally adjusted for place of residence in five major urban conurbations. Follow up period for both studies was from 1982-2000.
2.
All-cause mortality is significantly associated with PM 2.5 exposure, but the results are sensitive to statistical model specification and to the exposure model used to generate the estimates. When we applied control for residence in the largest urban conurbations, and we employed the land use regression (LUR) model, we found significantly elevated effects on all-cause mortality. For reasons explained in the main report this model specification with land use regression exposures and control for residence in the large conurbations is most likely to produce scientifically valid results. Many of the other results presented were included to satisfy contractual requirements to investigate methodological issues of interest to the Air Resources Board. When we use the fully specified models, the effect sizes are the same as those in the national study (see Abstract Table 1 for a comparison). We observed effects that were of similar size, but of borderline significance when using other exposure models.
3. The strongest and most consistent effects are observed when there is finer-scale spatial resolution in the exposure predictions. In models using the LUR estimate that serve as markers of relatively local variation in pollution we see all-cause effects from NO 2 and PM 2.5 (see Abstract Figure 1 for a comparison of the risks from statewide LUR models of PM 2.5 and NO 2 for various causes of death). 4. The strongest evidence of mortality effects is with exposure models that are markers of traffic-related air pollution. The NO 2 LUR estimate has significant associations with allcause, CVD, IHD, and lung cancer deaths. Exposure estimates based on roadway proximity had elevated, but insignificant risks, suggesting weaker effects than with the NO 2 model, probably due to increased exposure measurement error.
5.
With regard to other causes of death, there was no evidence of an air pollution effect. In fact for some regional PM 2.5 exposure there was some evidence of negative association, but when residence in the five largest urban conurbations was accounted for in the model, the effects became positive, but insignificant.
6. Other pollutants − namely PM 10 , sulfate derived from PM 10 filters, NO 2 , and ozone estimates from interpolation models − all showed consistent associations with CVD that are similar in size to those observed for PM 2.5 . In general, the interpolation estimates of these pollutants were highly correlated with each other and with PM 2.5 . Therefore caution must be exercised in interpreting effects from any single pollutant when the exposure estimate relies solely on interpolation.
CONCLUSION
Taken together, the results from this investigation indicate consistent and robust effects of PM 2.5 − and other pollutants commonly found in the combustion-source mixture with PM 2.5 − on deaths from CVD and IHD. We also found significant associations between PM 2.5 and all causes of death, although these findings were sensitive to model specification. In Los Angeles, where the monitoring network is capable of detecting intraurban variations in PM 2.5 , we observed large effects on death from all causes, CVD, IHD, and respiratory disease. These results were consistent with past ACS analyses and with findings from other national or international studies reviewed in this report. Our strongest results were from a land use regression estimate of NO 2 , which is generally thought to represent traffic sources, where significantly elevated effects were found on deaths from all causes, CVD, IHD, and lung cancer. We therefore conclude that combustion-source air pollution is significantly associated with premature death in this large cohort of Californians. In these analyses we sought to estimate the effects of PM 2.5 and other air pollutants on premature death in California. This study was motivated by earlier research from Los Angeles that showed PM 2.5 exerted a large, significant effect on all cause mortality and mortality from CVD and by a lack of statewide dose-response functions for benefits estimates. In the earlier analyses, effects for all causes, CVD, and IHD outcomes were larger than those observed in our national level studies using the ACS CPS II [5] . But in a more recent follow up [3] , the effects tended to increase for CVD and IHD in the national study and were of similar size to those observed in LA. The effects on all cause mortality were still about twice the size in LA compared to the recent national study, although they were more uncertain due to the smaller sample size. Consequently, uncertainty exists as to the effects that would be observed in a statewide model for California.
Below we summarize the key findings from the present investigation. We then offer narrative interpretation.
Key Findings

